Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2004-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2004508419-A |
titleOfInvention |
Shortening QT interval of ECG |
abstract |
The invention is particularly directed to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for shortening the QTc interval in patients with IDDM, and reducing the risk of sudden death or 'dead in bed' syndrome The use of a proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210077246-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021125387-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102371699-B1 |
priorityDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |